Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosmanogepix PK in ESRD on Hemodialysis
NCT07916181Phase 1Recruiting
- Sponsor
- Basilea Pharmaceutica
- Start
- Oct 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of fosmanogepix in fungal infection (2 arms), sponsored by Basilea Pharmaceutica. Primary endpoints: Maximum Plasma Concentration of manogepix, Area under the concentration-time curve of manogepix and 3 more. Started Oct 2026; status: recruiting.
02
Drugs
fosmanogepix
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT07916181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07916181.